EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD

被引：0
|
作者：
Fiore, F. [1 ]
Viviani, S. [2 ]
Luminari, S. [3 ]
Levis, A. [4 ]
Di Raimondo, F. [5 ]
Merli, F. [6 ]
Vitolo, U. [7 ]
Bolis, S. [8 ]
Federico, M. [8 ]
Gallamini, A. [1 ]
机构：
[1] Az Osped S Croce & Carle Cuneo, Dept Hematol, Cuneo, CN, Italy
[2] Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy
[3] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Modena, Italy
[4] Az Osped S Antonio & Biagio, Dept Hematol, Alessandria, Italy
[5] Univ Catania, Hematol Chair, Catania, Italy
[6] Arcispedale S Maria Nuova, Dept Hematol, Reggio Emilia, Italy
[7] Az Osped S Giovanni Battista, Dept Hematol, Turin, Italy
[8] Osped San Gerardo, Dept Hematol, Monza, Italy
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C061
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
    Kedmi, Meirav
    Apel, Arie
    Davidson, Tima
    Levi, Itai
    Dann, Eldad J.
    Polliack, Aaron
    Ben-Bassat, Isaac
    Nagler, Arnon
    Avigdor, Abraham
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 156 - 161
  • [22] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA, IMPROVES THE OVERALL TREATMENT OUTCOME OF ABVD: A GITIL MULTICENTER CLINICAL STUDY
    Gallamini, A.
    Fiore, F.
    Sorasio, R.
    Rambaldi, A.
    Patti, C.
    Stelitano, C.
    Viviani, S.
    Di Raimondo, F.
    Feldman, T.
    Biggi, A.
    Rossi, A.
    Mistretta, A.
    Bonfante, V.
    Chiarenza, A.
    Cantonetti, M.
    Gavarotti, P.
    Tarella, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 204 - 204
  • [23] Interim PET-Guided ABVD or ABVD/Escalated BEACOPP for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma (JCOG1305, INNOVATE-HL study)
    Kusumoto, Shigeru
    Munakata, Wataru
    Machida, Ryunosuke
    Terauchi, Takashi
    Onaya, Hiroaki
    Oguchi, Masahiko
    Iida, Shinsuke
    Nosaka, Kisato
    Suzuki, Yasuhiro
    Harada, Yasuhiko
    Miyazaki, Kana
    Maruta, Masaki
    Fukuhara, Noriko
    Toubai, Tomomi
    Kubota, Nobuko
    Ohmachi, Ken
    Yamamoto, Kazuhito
    Kumode, Takahiro
    Mizuno, Ishikazu
    Tabayashi, Takayuki
    Tsujimura, Hideki
    Takayama, Nobuyuki
    Asagoe, Kohsuke
    Yoshida, Isao
    Takamatsu, Yasushi
    Fukuhara, Suguru
    Takeuchi, Mai
    Tateishi, Ukihide
    Maruyama, Dai
    Tsukasaki, Kunihiro
    Nagai, Hirokazu
    BLOOD, 2022, 140 : 3718 - 3720
  • [24] Cost-Effectiveness of Interim PET Response Adapted Therapy In ABVD-Treated, Advanced-Stage Hodgkin Lymphoma
    Gallamini, Andrea
    Marchetti, Monia
    Borra, Anna
    Sorasio, Roberto
    Fiore, Francesca
    BLOOD, 2011, 118 (21) : 679 - 680
  • [25] Combined escBEACOPP-ABVD therapy for advanced Hodgkin's lymphoma patients with high ips score: An effective regimen and low positive predictive value of early FDG-PET/CT
    Aviador, A.
    Bulvik, S.
    Dann, E.
    Levi, I.
    Perez-Avraham, G.
    Shemtov, N.
    Shimoni, A.
    Nagler, A.
    Ben-Bassat, I.
    Polliack, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 66 - 66
  • [26] SEMI-QUANTITATIVE PARAMETERS TO IMPROVE THE INTERIM FDG-PET/CT POSITIVE PREDICTIVE VALUE IN HODGKIN LYMPHOMA
    Cuccaro, A.
    Annunziata, S.
    Galli, E.
    Bellesi, S.
    D'Alo, F.
    Calcagni, M. L.
    Giordano, A.
    Rufini, V.
    Hohaus, S.
    HAEMATOLOGICA, 2016, 101 : 41 - 42
  • [27] SEMI-QUANTITATIVE PARAMETERS TO IMPROVE POSITIVE PREDICTIVE VALUE OF INTERIM FDG-PET/CT IN HODGKIN LYMPHOMA
    Cuccaro, A.
    Annunziata, S.
    Rufini, V.
    Calcagni, M. L.
    Galli, E.
    D'Alo, F.
    Giordano, A.
    Hohaus, S.
    HAEMATOLOGICA, 2016, 101 : S34 - S34
  • [28] Combined escBEACOPP-ABVD therapy for advanced Hodgkin's lymphoma patients with high IPS score: An effective regimen and low positive predictive value of early FDG-PET/CT scan
    Avigdor, Abraham
    Bulvik, Shlomo
    Dann, Eldad
    Levi, Itai
    Perez-Avraham, Galit
    Shemtov, Noga
    Shimoni, Avichai
    Nagler, Arnon
    Ben-Bassat, Isaac
    Polliack, Aaron
    BLOOD, 2007, 110 (11) : 686A - 686A
  • [29] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee
    Dann, Eldad J.
    Paltiel, Ora
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 131 - 133
  • [30] PROGNOSTIC VALUE OF PRE-RADIOTHERAPY FDG-PET IN ADVANCED HODGKIN' S DISEASE TREATED BY BEACOPP CHEMOTHERAPY REGIMEN
    Chiesa, S.
    De Santis, M. C.
    Teofili, L.
    Manfrida, S.
    Vannata, B.
    Frascino, V.
    Fiorentino, A.
    Calcagni, L.
    Hohaus, S.
    Balducci, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S44 - S45
12345